No phaseRecruiting

Preserving Muscle Mass During Incretin-Induced Weight Loss (INCRETraIN)

Resistance Exercise Training to Preserve Muscle Mass and Physical Function During Incretin-Based Weight Loss

Sponsor
Karolinska Institutet (Academic or other)
Enrollment
20 planned
Conditions
Obesity (BMI > 35)
Interventions
Unilateral Resistance Training
Ages
adults
Registry
NCT07761923

Full record on ClinicalTrials.gov

From the registry

Treatment with incretin-based obesity medications leads to clinically meaningful weight loss and reduced cardiometabolic risk. However, the weight lost includes not only adipose tissue but also skeletal muscle, which may impair physical function and metabolic health. Resistance training is an effective strategy to maintain or increase skeletal muscle mass during weight loss, but its effects during treatment with incretin-based obesity medications have not been studied. This study will investigate whether unilateral resistance training during incretin-based receptor agonist treatment can preserve or improve skeletal muscle volume. The study will also examine whether training affects muscle strength and fatigue tolerance, body composition, cardiac structure and function, and molecular profiles in skeletal muscle, adipose tissue and blood. Participants will be women with obesity who are about to start treatment with an incretin-based receptor agonist as part of routine clinical care. During the 13-week intervention, participants will perform supervised unilateral resistance training…

Primary outcomes

  • Change in Anterior Thigh Skeletal Muscle Volume

History

  1. Study completion expected

  2. Primary completion expected

  3. Now recruiting

    , from Not yet recruiting to Recruiting

  4. Last registry update

  5. Started

  6. Registered